Cell Reports (Aug 2016)

Mechanism of TRIM25 Catalytic Activation in the Antiviral RIG-I Pathway

  • Jacint G. Sanchez,
  • Jessica J. Chiang,
  • Konstantin M.J. Sparrer,
  • Steven L. Alam,
  • Michael Chi,
  • Marcin D. Roganowicz,
  • Banumathi Sankaran,
  • Michaela U. Gack,
  • Owen Pornillos

DOI
https://doi.org/10.1016/j.celrep.2016.06.070
Journal volume & issue
Vol. 16, no. 5
pp. 1315 – 1325

Abstract

Read online

Antiviral response pathways induce interferon by higher-order assembly of signaling complexes called signalosomes. Assembly of the RIG-I signalosome is regulated by K63-linked polyubiquitin chains, which are synthesized by the E3 ubiquitin ligase, TRIM25. We have previously shown that the TRIM25 coiled-coil domain is a stable, antiparallel dimer that positions two catalytic RING domains on opposite ends of an elongated rod. We now show that the RING domain is a separate self-association motif that engages ubiquitin-conjugated E2 enzymes as a dimer. RING dimerization is required for catalysis, TRIM25-mediated RIG-I ubiquitination, interferon induction, and antiviral activity. We also provide evidence that RING dimerization and E3 ligase activity are promoted by binding of the TRIM25 SPRY domain to the RIG-I effector domain. These results indicate that TRIM25 actively participates in higher-order assembly of the RIG-I signalosome and helps to fine-tune the efficiency of the RIG-I-mediated antiviral response.